Jaguar Health, Inc. (JAGX) Operating cash flow 2016–2025
Jaguar Health, Inc. (JAGX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.7MFY2025 · since FY2016: -$14.4M → -$23.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.7M | +19.4% |
| FY2024 | -$29.4M | +11.6% |
| FY2023 | -$33.2M | -0.4% |
| FY2022 | -$33.1M | +5.3% |
| FY2021 | -$35.0M | -128.9% |
| FY2020 | -$15.3M | +25.3% |
| FY2019 | -$20.5M | +10.0% |
| FY2018 | -$22.7M | -131.4% |
| FY2017 | -$9.8M | +31.8% |
| FY2016 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →